Javascript must be enabled to continue!
Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome
View through CrossRef
Abstract
Introduction
The aim of this study was to determine incidence, risk factors, and impact on outcome of intensive care unit (ICU)-acquired Stenotrophomonas maltophilia.
Methods
This prospective observational case-control study, which was a part of a cohort study, was conducted in a 30-bed ICU during a three year period. All immunocompetent patients hospitalised >48 hours were eligible. Patients with non-fermenting Gram-negative bacilli (NF-GNB) at ICU admission were excluded. Patients without ICU-acquired S. maltophilia who developed an ICU-acquired NF-GNB other than S. maltophilia were also excluded. Screening (tracheal aspirate and skin, anal, and nasal swabs) for NF-GNB was performed in all patients at ICU admission and weekly. Univariate and multivariate analyses were performed to determine risk factors for ICU-acquired S. maltophilia and for ICU mortality.
Results
Thirty-eight (2%) patients developed an S. maltophilia ICU-acquired colonisation and/or infection and were all successfully matched with 76 controls. Chronic obstructive pulmonary disease (COPD) and duration of antibiotic treatment (odds ratio [OR] [95% confidence interval (CI)] = 9.4 [3 to 29], p < 0.001, and 1.4 [1 to 2.3], p = 0.001, respectively) were independently associated with ICU-acquired S. maltophilia. Mortality rate (60% versus 40%, OR [95% CI] = 1.3 [1 to 1.7, p = 0.037]), duration of mechanical ventilation (23 ± 16 versus 7 ± 11 days, p < 0.001), and duration of ICU stay (29 ± 21 versus 15 ± 17 days, p < 0.001) were significantly higher in cases than in controls. In addition, ICU-acquired infection related to S. maltophilia was independently associated with ICU mortality (OR [95% CI] = 2.8 [1 to 7.7], p = 0.044).
Conclusion
COPD and duration of antibiotic treatment are independent risk factors for ICU-acquired S. maltophilia. ICU-acquired S. maltophilia is associated with increased morbidity and mortality rates. ICU-acquired infection related to S. maltophilia is an independent risk factor for ICU mortality.
Springer Science and Business Media LLC
Title: Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome
Description:
Abstract
Introduction
The aim of this study was to determine incidence, risk factors, and impact on outcome of intensive care unit (ICU)-acquired Stenotrophomonas maltophilia.
Methods
This prospective observational case-control study, which was a part of a cohort study, was conducted in a 30-bed ICU during a three year period.
All immunocompetent patients hospitalised >48 hours were eligible.
Patients with non-fermenting Gram-negative bacilli (NF-GNB) at ICU admission were excluded.
Patients without ICU-acquired S.
maltophilia who developed an ICU-acquired NF-GNB other than S.
maltophilia were also excluded.
Screening (tracheal aspirate and skin, anal, and nasal swabs) for NF-GNB was performed in all patients at ICU admission and weekly.
Univariate and multivariate analyses were performed to determine risk factors for ICU-acquired S.
maltophilia and for ICU mortality.
Results
Thirty-eight (2%) patients developed an S.
maltophilia ICU-acquired colonisation and/or infection and were all successfully matched with 76 controls.
Chronic obstructive pulmonary disease (COPD) and duration of antibiotic treatment (odds ratio [OR] [95% confidence interval (CI)] = 9.
4 [3 to 29], p < 0.
001, and 1.
4 [1 to 2.
3], p = 0.
001, respectively) were independently associated with ICU-acquired S.
maltophilia.
Mortality rate (60% versus 40%, OR [95% CI] = 1.
3 [1 to 1.
7, p = 0.
037]), duration of mechanical ventilation (23 ± 16 versus 7 ± 11 days, p < 0.
001), and duration of ICU stay (29 ± 21 versus 15 ± 17 days, p < 0.
001) were significantly higher in cases than in controls.
In addition, ICU-acquired infection related to S.
maltophilia was independently associated with ICU mortality (OR [95% CI] = 2.
8 [1 to 7.
7], p = 0.
044).
Conclusion
COPD and duration of antibiotic treatment are independent risk factors for ICU-acquired S.
maltophilia.
ICU-acquired S.
maltophilia is associated with increased morbidity and mortality rates.
ICU-acquired infection related to S.
maltophilia is an independent risk factor for ICU mortality.
Related Results
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study
Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study
Abstract
Background
There is little descriptive data on Stenotrophomonas maltophilia hospital-acquired pneumonia (HAP) in critically ill patients. T...
Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus
Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus
SummaryStenotrophomonas maltophilia, a bacterium ubiquitous in the environment, is also an opportunistic, multidrug‐resistant human pathogen that colonizes tissues and medical devi...
Isolation and genomic characterization of metal-resistant Stenotrophomonas maltophilia SRM01 from the marine environment
Isolation and genomic characterization of metal-resistant Stenotrophomonas maltophilia SRM01 from the marine environment
Abstract
Stenotrophomonas maltophilia is an emerging global opportunistic pathogen that has been intensively studied for its antibiotic resistance and capacity to cause nos...
Honeydew honey as a potent antibacterial agent in eradication of multi‐drug resistant Stenotrophomonas maltophilia isolates from cancer patients
Honeydew honey as a potent antibacterial agent in eradication of multi‐drug resistant Stenotrophomonas maltophilia isolates from cancer patients
AbstractMulti‐drug resistance in nosocomial pathogens is a continually evolving and alarming problem in health care units. Since ancient times, honey has been used successfully for...
Obstetric admission and maternal mortality in the intensive care unit in Africa: A systematic review and meta-analysis
Obstetric admission and maternal mortality in the intensive care unit in Africa: A systematic review and meta-analysis
Background
Obstetric complications are a major contributor to maternal morbidity and mortality worldwide, especially in low-resource settings such as many countries in Africa. Inte...
Microbiological Landscape of Intensive Care Unit: A Retrospective Analysis of Bacterial Pathogens and Their Implications
Microbiological Landscape of Intensive Care Unit: A Retrospective Analysis of Bacterial Pathogens and Their Implications
Introduction: The intensive care unit (ICU) is a high-risk environment for hospital-acquired infections (HAIs) due to the complex interplay of patient vulnerability, invasive proce...
Genomic Analysis of the Endophytic Stenotrophomonas Strain 169 Reveals Features Related to Plant-Growth Promotion and Stress Tolerance
Genomic Analysis of the Endophytic Stenotrophomonas Strain 169 Reveals Features Related to Plant-Growth Promotion and Stress Tolerance
Plant-associated Stenotrophomonas isolates have great potential for plant growth promotion, especially under stress conditions, due to their ability to promote tolerance to abiotic...


